Introduction
============

MicroRNA (miRNA) is a small non-coding single-stranded RNA molecule with a length of approximately 22 nucleotides. miRNAs assume several key regulatory functions, such as cell growth, tissue differentiation, cell proliferation, embryonic development and cell apoptosis ([@b1-mmr-14-02-1631]). The involvement of miRNAs in various tumors and cardiovascular diseases has been reported ([@b1-mmr-14-02-1631],[@b2-mmr-14-02-1631]). An abnormal miRNA level has been reported in many diseases including myocardial infarction ([@b2-mmr-14-02-1631]). Results from those studies demonstrated that the abnormal expression was found uniquely in the case of specific miRNAs and their overexpression was used as genotype markers ([@b3-mmr-14-02-1631]).

Early stage myocardial infarction is a serious health condition and timely diagnosis and treatment have an important impact on the quality of life of patients. Functional genomic research revealed that microRNA-208a (miR-208a) was solely expressed in the cardiac muscle cells, and released into the bloodstream after the occurrence of myocardial damage ([@b4-mmr-14-02-1631]). However, to the best of our knowledge, no study reported the expression levels of miR-208a in myocardial infarction.

In this study, we examined the expression level of miR-208a in rat myocardial infarction tissue and the level of miR-208a in the serum. We also studied the possible effects of the miR-208a level on the cAMP-PKA pathway in myocardial injuries.

Materials and methods
=====================

Establishment of the early stage myocardial infarction rat model
----------------------------------------------------------------

Male Sprague-Dawley rats weighing 200 to 220 g, were obtained from the Experimental Animal Center of Fengxian Hospital (Shanghai, China), were divided into two groups. Rats in the sham operation group were given thoracotomy without ligation of coronary artery, while rats in the myocardial infarction group were fed for another 8 weeks after ligation of anterior descending coronary artery. After administration of chloral hydrate (10%, 350 mg/kg) to rats in the myocardial infarction group under anesthesia, the neck skin was incised longitudinally, while limbs and head were fixed in the supine position, exposing the trachea after blunt separation. The trachea was cut between the second and third cricoid cartilage and the animal ventilator was inserted into the trachea after intubation for artificial respiration. Skin was incised in the 3rd to 4th intercostal along the rib gap on the left side of the sternum. Subcutaneous tissue and muscle were then separated layer by layer. The chest was entered in the 3rd to 4th intercostal to expose the heart. Initial portion of the left anterior descending coronary artery was located between the left atrial appendage margin and the pulmonary cone. The left anterior descending coronary artery was ligated with a wisp of myocardia. After ligation, the left ventricular wall turned pale, and ventricular wall motion decreased.

The rat model
-------------

The ST segment of lead II in ECG monitor was significantly higher. Chest was monitored for 10 min and then closed layer by layer after thorough hemostasis. Spontaneous breathing was recovered and the trachea as well as the neck incisions were sutured. Rats in the sham operation group were only treated with open thoracic puncture needle without ligation of the coronary artery. After the experiment, rats in the sham operation group were in good condition with smooth hair and were active and agile. The nutritional status of rats in the myocardial infarction group was poor. The hair was messy and sparse, and the movement of the rats was slow with less activity.

Ethics approval for the animal experiments was received from the Medical Ethics Committee of Fengxian Hospital.

Experimental method
-------------------

### Total RNA extraction, serum collecting and reverse transcription reactions

#### Serum extraction

Peripheral venous blood was collected from the two groups and EDTA anticoagulant was added to the samples. Samples were centrifuged at 4,000 × g for 5 min at 4°C. After centrifugation, the serum was kept at −80°C. TRIzol (1 ml; Gibco, Carlsbad, CA, USA) was added to approximately 100 mg of tissue or 100 *µ*l of serum. Samples were homogenized and total RNA was extracted. Extracted RNA was dissolved in 30 *µ*l DEPC water and reverse transcription kit (Thermo Fisher Scientific, Waltham, MA, USA) was used for reverse transcription.

#### PCR reaction conditions

PCR was set for 40 cycles (denaturation at 95°C for 20 sec, renaturation at 60°C for 20 sec and extension at 70°C for 1 sec). Primers used were: *miR-208a* forward, 5′-GTCATCTAGAAAGCTTGATGCAGGAAA GAGCTTTGG-3′ and reverse, 5′-TGACAGATCTCAGCTGA CATCCTCTAGGCTGGGGTT-3′ ([@b5-mmr-14-02-1631]); U6 control forward, 5′-CTCGCTTCGGCAGCACA-3′ and reverse 5′-AACGCT TCACGAATTTGCGT-3′.

PCR was conducted with ABI PCR, model 7900 (Applied Biosystems, Foster City, CA, USA). The relative quantitative analysis was performed using the 2^−ΔΔCt^ method ([@b6-mmr-14-02-1631]).

#### Cell transfection

Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was used for myocardial cell line transfection using miR-208a stimulant (mimic; Guangzhou Ruibo Biotechnology Co., Ltd., Guangzhou, China). The interference efficiency was evaluated after 48 h.

#### Evaluation of protein expression by western blotting

HCM cells were collected and treated with 1X SDS cell lysis buffer (Beyotime Inc., Shanghai, China). After SDS-PAGE, the proteins were transferred to the PVDF membrane (Millipore, Shanghai, China) at 110 V for 90 min. The membranes were blocked at 37°C for 100 min and then incubated with polyclonal goat anti-human PKA (R&D Systems, Inc., Minneapolis, MN, USA cat no. AF4177, 1:500 dilution) and monoclonal mouse anti-human cAMP antibody (R&D Systems, Inc., Minneapolis, MN, USA, cat no. MAB2146, 1:500 dilution) at 4°C overnight. Subsequently, the membranes were rinsed and incubated with anti-goat secondary (PKA, cat. no. ab339770) and HRP-mouse secondary (cAMP, cat. no. ab157532) antibodies (1:2,000; Abcam, Cambridge, MA, USA) at 37°C for 30 min. The reference protein used in this study was rabbit polyclonal to human β-actin (ab8227, 1:500) (Sigma, St. Louis, MO, USA).

#### Statistical analysis

Data were analyzed using SPSS 19.0 software (SPSS software Inc., Chicago, IL, USA). The differences between the two groups were compared using the Student\'s t-test. P\<0.05 was considered statistically significant.

Results
=======

Expression levels of miR-208a in the rat myocardial tissues
-----------------------------------------------------------

The expression levels of miR-208a in myocardial tissue in rats with early myocardial infarction were significantly higher than those in control group (P\<0.05) ([Table I](#tI-mmr-14-02-1631){ref-type="table"}).

miR-208a levels in the serum
----------------------------

For rats with subacute myo cardial infarction we detected higher levels of miR-208a in the serum. The difference observed between the myocardial infarction and the control group was statistically significant (P\<0.05) ([Table II](#tII-mmr-14-02-1631){ref-type="table"}).

cAMP-PKA expression levels in the rat myocardial tissues
--------------------------------------------------------

The expression levels of cAMP-PKA protein in the myocardial tissue in rats with early myocardial infarction were significantly higher than those in the control group (P\<0.05) ([Fig. 1](#f1-mmr-14-02-1631){ref-type="fig"}).

The effects of miR-208a overexpression on the cAMP-PKA expression levels in cardiac muscle cells
------------------------------------------------------------------------------------------------

Transfecting cells with the miR-208a stimulation increased the expression levels of the miR-208a ([Fig. 2A](#f2-mmr-14-02-1631){ref-type="fig"}). High levels of miR-208a expression significantly upregulated the cAMP-PKA protein expression ([Fig. 2B and C](#f2-mmr-14-02-1631){ref-type="fig"}).

The differences observed between the experimental and control groups were statistically significant.

Discussion
==========

Acute myocardial infarction is a multi-factor related disease on the basis of atherosclerosis. Its clinical manifestation is intense and persistent chest pain. Resting or taking nitrates usually cannot induce complete remission. Acute myocardial infarction is often accompanied by an increase in serum myocardial enzyme and troponin activity. We also observed severe and dangerous electrocardiogram changes. Acute myocardial infarction can cause severe damage to patients and has a high disability rate as well as high mortality rate ([@b7-mmr-14-02-1631]). Effective and timely medical intervention is an important element to reduce the devastating impact of myocardial infarction and to improve the survival rates of the patients suffering from this condition. At present, laboratory diagnosis of acute myocardial infarction is obtained by measuring serum myocardial damage markers (myocardial enzymes and troponin) ([@b2-mmr-14-02-1631]). However, there are some shortcomings, such as poor specificity and short duration. Therefore, it is imperative to identify a more specific marker for the treatment and prognosis of acute myocardial infarction.

miRNA is a class of single-stranded short chain non-encoding small RNA fragments with regulatory effects on human genes. miRNAs is important in the process of cell differentiation and apoptosis ([@b8-mmr-14-02-1631]--[@b12-mmr-14-02-1631]). In recent years, the importance of miRNA as an endogenous factor in myocardial ischemia has been demonstrated. Prior studies showed that miRNA was involved in the pathological process of myocardial infarction and fibrosis process after myocardial infarction. For example, it was found that miR-199a levels in a rat model of acute myocardial infarction tissue decreased significantly and were involved in the regulation of myocardial hypoxia by regulating the hypoxia-inducible factor (HIF-1α) expression level ([@b13-mmr-14-02-1631],[@b14-mmr-14-02-1631]). Rane *et al* found that miR-21, miR-214 and miR-223 in the myocardial infarction margin in patients with myocardial infarction increased significantly, while miR-29b and miR-149 significantly decreased ([@b14-mmr-14-02-1631]). Previous genomic studies demonstrated that miR-208a exists in the human body, and its expression in patient peripheral blood following myocardial infarction was increased ([@b4-mmr-14-02-1631]). To the best of our knowledge, there are only few studies that focus on the level of miR-208a in animal models for acute myocardial infarction and the mechanism of myocardial injury.

In the present study, the expression levels of miR-208a in the serum as well as the tissue were detected in an acute myocardial infarction rat model. The aim was to examine the function and mechanism of miR-208a involvement in the pathogenesis of acute myocardial infarction. The levels of miR-208a in the myocardial tissue and the serum were significantly higher in rats with acute myocardial infarction suggesting that miR-208a may be involved in the occurrence and development of acute myocardial infarction. We hypothesized that miR-208a is released into the blood after myocardial infarction. This is consistent with a previous study conducted on patients with myocardial infarction ([@b4-mmr-14-02-1631]).

The cAMP-PKA pathway is a part of the receptor G protein and cAMP-PKA signaling pathway, which plays a key role in mediating cell responses to various stimuli ([@b15-mmr-14-02-1631]). The cAMP-PKA pathway can mediate a variety of physio logical and pathological functions, especially in cardiovascular disease, such as the expansion of coronary artery and enhanced myocardial contractility ([@b16-mmr-14-02-1631]). The results of this study showed that cAMP-PKA protein levels in myocardial tissue were significantly higher in rats with subacute myocardial infarction compared to those in sham-operated rats. This findings showed that myocardial injury was involved in the occurrence of myocarditis by promoting the cAMP-PKA protein signaling pathway. Furthermore, the effect of miR-208a on the cAMP-PKA protein signaling pathway in myocardial cells was studied by overexpressing the miR-208a in human myocardial cells. It was found that the overexpression of miR-208a, significantly upregulated the cAMP-PKA expression. This result suggests that miR-208a is probably involved in the inflammatory process of acute myocardial infarction by affecting the cAMP-PKA signaling pathway.

In conclusion, we have demonstrated that the expression of miR-208a increased during the acute myocardial infarction and may be involved in the development of myocardial infarction by regulating the cAMP-PKA signaling pathway. We also suggest that our study showed that the detection of miR-208a in the serum of patients with subacute myocardial infarction can be used as a potential diagnostic indicator/marker for myocardial injuries.

![The cAMP-PKA protein expression levels in the rat myocardial tissues (both groups). ^\*^ P\<0.05, compared with the control group.](MMR-14-02-1631-g00){#f1-mmr-14-02-1631}

![The effect of miR-208a stimulation on the expression levels of the miR-208a (A). The effect of miR-208a overexpression on cAMP-PKA levels in human myocardial cells (B and C). ^\*^ P\<0.05, compared with the blank group; ^\*\*\*^ P\<0.005, compared with the blank group. miR-208a, microRNA-208a.](MMR-14-02-1631-g01){#f2-mmr-14-02-1631}

###### 

Expression levels of miR-208a in rat myocardial tissues.

  Group (n)                         miR-208a miRNA   t/P-value
  --------------------------------- ---------------- ----------------------------------------------------------
  Control ([@b12-mmr-14-02-1631])   1.21±0.31        
  Study ([@b12-mmr-14-02-1631])     4.21±1.41        7.20/0.000[a](#tfn1-mmr-14-02-1631){ref-type="table-fn"}

Compared with the rat myocardial tissue in the control group. t=7.20, P\<0.05. miR-208a, microRNA-208a; miRNA, microRNA.

###### 

miR-208a levels in the serum.

  Group (n)                         miR-208a miRNA                                            t/P-value
  --------------------------------- --------------------------------------------------------- ------------
  Control ([@b12-mmr-14-02-1631])   1.29±0.41                                                 
  Study ([@b12-mmr-14-02-1631])     3.24±1.39[a](#tfn2-mmr-14-02-1631){ref-type="table-fn"}   4.66/0.000

Compared with the rat myocardial tissue in the control group. t=7.20, P\<0.05. miR-208a, microRNA-208a; miRNA, microRNA.
